MidMarketNow exists to make the mid-market transparent, understandable, and actionable. We help investors, entrepreneurs, and decision-makers cut through noise, see opportunities earlier, and make better decisions with confidence.
Browse All ArticlesMidMarketNow Weekly 2026-W41: Italy dominated flow as sponsors leaned into healthcare, payments platforms, and ‘boring’ compliance assets—while rates stayed pesky.
London-based IMMIX has raised EUR 3.5 million from Crane Venture Partners, BTSE and Portfolio Ventures to build FX infrastructure for non-USD stablecoin payments and cross-border settlement.
IMMIX fundingStrategic Management Partners has acquired a 60% stake in Italian GRC specialist Gesta, positioning it as the group’s governance, risk and compliance hub to support domestic and international expansion.
Strategic Management PartnersMonforte Capital Partners has acquired 100% of Italy’s iKN Institute of Knowledge & Networking, adding another platform in managerial training and business events.
Monforte Capital PartnersItalian surgical robotics specialist Medical Microinstruments raised $125 million (~EUR 116m) in a Series D led by BioStar Capital, with S3 Ventures and Angelini Ventures participating.
Medical MicroinstrumentsGarofalo Health Care has acquired Casa di Cura Malatesta Novello in Cesena for EUR 69.3 million, extending its Emilia-Romagna footprint as consolidation among SSN-accredited operators continues.
Garofalo Health CareZest has completed its exit from Italian fintech Epic Holding, crystallising a 3.5x MOIC and a roughly EUR 0.86 million distribution. The result underlines a patient-capital playbook in Italy’s active financial-services deal market.
Zest